From Reactive to Proactive: How AI Is Changing the Way Medical Affairs Works
Medical Affairs is undergoing a fundamental shift in how it operates within pharmaceutical organizations. Historically, much of its...
Medical Affairs is undergoing a fundamental shift in how it operates within pharmaceutical organizations. Historically, much of its...
Medical education is undergoing a significant transformation. Traditionally, preceptorship programs have been anchored within hospital settings, where healthcare...
Artificial intelligence is rapidly transforming how the pharmaceutical industry can process scientific information, generate insights, and design evidence...
Scientific congresses have long been central to the Medical Affairs (MA) ecosystem, serving as critical venues for knowledge...
Medical Affairs is entering a new phase in which scientific planning is becoming more predictive, data-driven, and strategically...
Medical education is undergoing a fundamental redefinition. For decades, the dominant model relied on episodic touchpoints—annual congresses, stand-alone...
Medical Affairs is entering a decisive new era—one defined not simply by digital tools, but by artificial intelligence...
Next-Generation Advisory Boards: Hybrid Formats, Patient Voices, AI Insights & Global Reach Advisory boards are undergoing one of...
The years between 2025 and 2030 represent a defining era for Medical Affairs (MA). The post-pandemic period has...
The transformation of Medical Affairs over the past decade has been profound. Once seen largely as an operational...
The COVID-19 pandemic catalyzed one of the most significant evolutions in modern research—the emergence of Decentralized Clinical Trials...
The pharmaceutical industry is navigating through an unprecedented surge of unstructured medical information these days, which ranges from...
The rapid advancement of artificial intelligence (AI) in healthcare and the pharmaceutical industry is transforming how knowledge is...
In today’s pharmaceutical landscape, patient-centricity has evolved from a strategic aspiration to an operational necessity. Healthcare stakeholders, from...
Artificial intelligence (AI) has become one of the most transformative forces in modern healthcare, driving remarkable progress in...
Oncology is undergoing a paradigm shift. The era of standardized, one-size-fits-all cancer treatments is being replaced by precision...
Transparency in healthcare is no longer a differentiator—it is an expectation. As patients evolve into proactive stakeholders in...
The Medical Science Liaison (MSL) has long been recognized as a critical bridge between pharmaceutical companies and the...
Picture a seasoned emergency physician between trauma cases, a surgical resident commuting home after a 12-hour shift, or...
Over the last decade, the pharmaceutical industry has undergone one of its most profound paradigm shifts, accelerated by...
Contemporary medical education faces multiple challenges: limited access to clinical cases, inconsistent exposure to rare procedures, ethical considerations...
The healthcare industry is undergoing a digital transformation, with data emerging as one of its most valuable assets....
The pharmaceutical landscape is evolving rapidly, driven by scientific advancements, regulatory changes, and an increasing emphasis on patient-centered...
Artificial Intelligence (AI) is revolutionizing the pharmaceutical industry, driving drug discovery and personalized medicine breakthroughs. Traditional drug development...
The role of Medical Science Liaisons (MSLs) in the pharmaceutical industry is evolving rapidly. As scientific experts, MSLs...
Personalized medicine is revolutionizing the way diseases are diagnosed and treated by specified medical interventions to an individual’s...
The healthcare landscape is evolving rapidly, driven by groundbreaking technological advancements and the urgent need to address global...
Every year, millions of lives are lost to preventable diseases, yet solutions often remain out of reach for...
Sustainability has become a cornerstone for industries worldwide as they navigate the challenges of climate change, resource scarcity,...
The pharmaceutical industry has long relied on a traditional model of drug discovery, development, and distribution. While effective,...
Patient advocacy is a cornerstone of modern healthcare, serving as a vital mechanism for ensuring that patients have...
The pharmaceutical and healthcare sectors are undergoing a profound transformation, driven by advances in data science and the...
The pharmaceutical industry stands at the forefront of medical innovation, continually evolving in response to scientific breakthroughs and...
Continuous medical education (CME) has become an essential pillar of healthcare to ensure that healthcare professionals remain at...
The healthcare industry, particularly the pharmaceutical sector, has increasingly recognized the importance of a patient-centric approach. This paradigm...
Author: Natalia Denisova, PhDVP, Head of Medical Affairs, MphaR Download in PDF The rapid integration of artificial intelligence...
How to run an interactive MSLs training in a virtual format for continued efficiency and excellence Before Covid-19,...
In recent years, technology has advanced at an incredible rate, fundamentally changing how people interact, get information, and...
The Role of Medical Affairs in Promoting Environmental Sustainability: Lessons Learned Imagine a world where healthcare specialists treat...
Fostering Global Collaboration in Healthcare for Sustainable Solutions: Leveraging the Digital Tool for Scientific Events The COVID-19...
In the constantly developing healthcare landscape, cognizance of disease ecosystems has appeared as a focal idea in research...
Since its inception in 1967, the role of Medical Science Liaisons (MSLs) has progressively evolved from being information-centric...
There's no doubt that the pharmaceutical industry has always functioned as a cornerstone in massively contributing towards global...
The Evolving Role of Medical Science Liaisons (MSLs): How the Role of MSLs is Changing in Response to...
It's safe to say that the COVID-19 outbreak was a powerful catalyst for the recent advancements and evolution...
The importance of having exceptional communication skills can never be overemphasized, especially when you talk about the healthcare...
Author: Natalia Denisova, PhDVP, Head of Medical Affairs, MphaR Download in PDF The Covid-19 pandemic resulted in exponential...
Author: Natalia Denisova, PhDVP, Head of Medical Affairs, MphaR Download in PDF The harrowing effects of global warming...
Global warming Earth’s global average temperature in 2021 has been crowned as the sixth warmest on record, according...
The four pillars holding the healthcare industry together include health services, pharmaceuticals, finances and medical devices. These provide...
Virtual advisory boards: what pharma learned in 2020 and new trends for the Post-COVID Era 2020 was the...
Introduction Advantages of using virtual advisory board (VAB) platforms include company savings on flights and hotels fares and...
Digital interactions with HCPs — moving from Webinars to a more interactive communication tool: a new normal for...
Remote work has been the new custom for several individuals as branch offices were closed due to the...
In this professional milieu, virtual events, conferences, and seminars are nothing new but evidently too mainstream. The notion...
Covid-19 has propelled medical science to have an unparalleled chance of accelerating and executing technology-driven adjustments to the...
Since the COVID-19 outbreak, the healthcare industry implemented different techniques to make interactions between pharmaceutical companies, healthcare professionals,...
The MphaR team was pretty busy in June. There were a lot of important clinical trials summits requiring...
When building the Virtual Advisory Board Platform, we wanted to create a new approach to how healthcare professionals...
When we were starting to build Virtual Advisory Board Platform, we aimed to create a tool that could...
In February Natalia Denisova, PhD, Vice President, Head of Medical Affairs, and Sara Frau, PhD, Scientific Director Oncology,...
Thank you! Your message has been sent.